B.S./M.S./Ph.D. (China Pharmaceutical University)

Dr. Zhaoting Li now works as an Assistant Professor (PI) in the School of Medicine at the Chinese University of Hong Kong, Shenzhen. He completed his B.S./M.S./Ph.D. at China Pharmaceutical University and postdoctoral training at the School of Pharmacy, University of Wisconsin-Madison. In recent five years, as the first or corresponding author, he has published more than ten representative papers in prestigious journals such as PNAS, Nature Communications, Science Advances, Chemical Society Reviews, Advanced Materials, Advanced Functional Materials, Advanced Drug Delivery Reviews, Journal of Controlled Release, etc. His research mainly focuses on cell therapy, living system-based drug delivery, and immunotherapy. His research has been cited by Nature Reviews Materials, Chemical Society Reviews, etc., and featured in Nature Communications Editors' Highlights. Dr. Zhaoting Li serves as a Guest Editor for Frontiers in Bioengineering and Biotechnology and the Young Editor Board Member for Asian Journal of Pharmaceutical Sciences and Nano Materials Science.

Representative publications

1. Z. Li, F. Mo, Y. Wang, W. Li, Y. Chen, J. Liu, Ting-Jing Chen-Mayfield, Q. Hu, Enhancing Gasdermin-Induced Tumor Pyroptosis Through Preventing ESCRT-Dependent Cell Membrane Repair Augments Anti-Tumor Immune Response, Nature Communications, 13, 6321, 2022.

2. Z. Li, Y. Ding, J. Liu, J. Wang, F. Mo, Y. Wang, P. Sondel, S. Hong, Q. Hu, Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment, Nature Communications, 13, 1845, 2022.

3. Z. Li, L. Zhu, H. Sun, Y. Shen, D. Hu, W. Wu, Y. Wang, C. Qian, M. Sun, Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot, PNAS, vol. 117 no. 49, 2020.

4. Z. Li, Y. Wang, Y. Shen, C. Qian, D. Oupicky, M. Sun, Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy, Science Advances, eaaz9240, 2020.

5. Y. Wang#, Z. Li#, F. Mo, T. Mayfield, A. Sainia, A. LaMerea, Q. Hu, Chemically Engineering Cells for Precision Medicine, Chemical Society Reviews, 2023, 52, 1068-1102. Co-first author.

6. Z. Li, Y. Wang, J. Liu, P. Rawding, J. Bu, S. Hong, Q. Hu, Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy, Advanced Materials, 33(38), 2021, e2102580.

7. Y. Ding#, Z. Li#, A. Jaklenec, Q. Hu, Vaccine delivery systems toward lymph nodes, Advanced Drug Delivery Reviews, 2021 Dec:179:113914. Co-first author.

8. Z. Li, Y. Wang, Y. Ding, L. Repp, G. Kwon, Q. Hu, Cell-Based Delivery Systems: Emerging Carriers for Immunotherapy, Advanced Functional Materials, 31 (23), 2021.

9. L. Zhu#, Z. Li#, N. Liu, H.H. Sun, Y.X. Wang, M.J. Sun, Dynamically Deformable Protein Delivery Strategy Disassembles Neutrophil Extracellular Traps to Prevent Liver Metastasis, Advanced Functional Materials, 31, 2021. Co-first author.

10. Z. Li, Y. Deng, C. Tan, H. Sun, H. Li, F. Mo, Y. Wang, J. Li, Z. Zhou, M. Sun, Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity, Journal of Controlled Release, 2023 Jun:358:579-590.